NDC 80425-0121-01 - Cephalexin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0121
- Requested NDC
- 80425-0121-01
- Package NDCs from labels
- 80425-0121-4, 80425-0121-1, 80425-0121-2, 80425-0121-3, 80425-0121-5, 80425-0121-6, 80425-0121-7, 80425-0121-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-01-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cephalexin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-01-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0121-1 | Cephalexin | 28 in 1 BOTTLE | CAPSULE | 28 | 10 | |
| 80425-0121-2 | Cephalexin | 40 in 1 BOTTLE | CAPSULE | 40 | 10 | |
| 80425-0121-3 | Cephalexin | 30 in 1 BOTTLE | CAPSULE | 30 | 10 | |
| 80425-0121-4 | Cephalexin | 20 in 1 BOTTLE | CAPSULE | 20 | 10 | |
| 80425-0121-5 | Cephalexin | 14 in 1 BOTTLE | CAPSULE | 14 | 10 | |
| 80425-0121-6 | Cephalexin | 5 in 1 BOTTLE | CAPSULE | 5 | 10 | |
| 80425-0121-7 | Cephalexin | 6 in 1 BOTTLE | CAPSULE | 6 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0121 | CEPHALEXIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 10 | Current NDC, Legacy NDC, 7 package rows | 20240119_b6ffe633-dd91-6d49-e053-2a95a90a5ac6.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0121-1 | EA - Each | 80425-0121 | b098bd7f-bb96-4b61-a21d-97eace448f0c | 1 | 2023-03-13 |
| 80425-0121-2 | EA - Each | 80425-0121 | 426ea2b8-26c1-43e8-a5b1-1672b92f5233 | 1 | 2023-03-13 |
| 80425-0121-3 | EA - Each | 80425-0121 | 7fc1df44-2cd9-4b79-ae4c-de04aadf60a9 | 1 | 2023-03-13 |
| 80425-0121-4 | EA - Each | 80425-0121 | 565cd629-53b3-43a8-a2d5-ea15be49d06e | 1 | 2023-03-13 |
| 80425-0121-5 | EA - Each | 80425-0121 | d48bfbc1-a630-44dc-a60e-afcb09a91657 | 1 | 2023-03-13 |
| 80425-0121-6 | EA - Each | 80425-0121 | 2aca4026-c892-49c5-a382-fcec45451772 | 1 | 2023-10-16 |
| 80425-0121-7 | EA - Each | 80425-0121 | dd7a169c-9ad3-407c-8d7b-6183f03ecc0e | 1 | 2024-06-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | cf1c5d03-eddc-463a-84ad-4d59362c2cf8 | 2026-07-14 | Warnings, Adverse reactions | ANDA090836 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Northwind Health Company, LLC | 1d0d50ba-8c2c-855c-e063-6394a90a5c7d | 2026-07-09 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Ascend Laboratories, LLC | 4fec8daf-6e09-4153-926f-64709dbdd26c | 2026-06-17 | Warnings, Adverse reactions | ANDA090836 67877-219 309114 637173 645617 309112 b0eb4846-bf8b-4322-b8c6-bfb2c252d5d4 4fec8daf-6e09-4153-926f-64709dbdd26c OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Unit Dose Solutions, Inc. | 53704ffd-b4f6-8b61-e063-6394a90a01f9 | 2026-06-04 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Proficient Rx LP | 7059a0b2-dd57-4fc1-ac3d-6aead35a4b08 | 2026-06-01 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| cephalexin | CEPHALEXIN | Lupin Pharmaceuticals, Inc. | 25ef498a-7a7e-4543-a544-b9d0e99f9cd9 | 2026-06-01 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Coupler LLC | 508a3401-df0b-0555-e063-6294a90a155a | 2026-04-28 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 8a938dd0-fca6-4f22-9fb0-632596603001 | 2026-04-20 | Warnings, Adverse reactions | 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 06c2fb2e-0539-4f16-bac4-e15a575ca802 | 2026-04-03 | Warnings, Adverse reactions | OBN7UDS42Y |
| CEPHALEXIN | CEPHALEXIN | Direct_Rx | 90051655-77e9-6753-e053-2a95a90a462c | 2026-03-26 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| cephalexin | CEPHALEXIN | Preferred Pharmaceuticals Inc. | 553485f8-890d-4929-a6bb-905221cf411d | 2026-03-25 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Preferred Pharmaceuticlas Inc. | fbf5fcdf-40fc-40e5-b784-308032fff0e5 | 2026-03-25 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Preferred Pharmaceuticals, Inc. | 6c7bfa58-2d38-4607-8c33-485ba4931c68 | 2026-03-25 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Preferred Pharmaceuticals Inc. | 52d8a080-eafc-46fe-82d9-6b69c6a3a38a | 2026-03-25 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Preferred Pharmaceuticals Inc. | ad676021-44f3-4a97-a3dc-28a62fe982bb | 2026-03-25 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Sportpharm LLC | da97ca40-3b22-432b-a3e9-0902dbef06a9 | 2026-03-21 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | 3fed2817-fc0d-43cd-9f02-948fbc76672c | 2026-03-18 | Warnings, Adverse reactions | 309112 OBN7UDS42Y |
| CEPHALEXIN | CEPHALEXIN | Direct_Rx | 90148caf-4291-da8b-e053-2a95a90a9bd3 | 2026-03-16 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Sportpharm LLC | 3d5a2665-65da-4b10-9e23-39fc88145da1 | 2026-02-03 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Sportpharm LLC | 75820198-5efe-4ba0-ad50-e88d22fe075e | 2026-02-03 | Warnings, Adverse reactions | ANDA090836 309112 OBN7UDS42Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.